374 related articles for article (PubMed ID: 36561746)
1. B7 family protein glycosylation: Promising novel targets in tumor treatment.
Xiao L; Guan X; Xiang M; Wang Q; Long Q; Yue C; Chen L; Liu J; Liao C
Front Immunol; 2022; 13():1088560. PubMed ID: 36561746
[TBL] [Abstract][Full Text] [Related]
2. The Positive and Negative Immunoregulatory Role of B7 Family: Promising Novel Targets in Gastric Cancer Treatment.
Bolandi N; Derakhshani A; Hemmat N; Baghbanzadeh A; Asadzadeh Z; Afrashteh Nour M; Brunetti O; Bernardini R; Silvestris N; Baradaran B
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639059
[TBL] [Abstract][Full Text] [Related]
3. B7 Family Members in Lymphoma: Promising Novel Targets for Tumor Immunotherapy?
Zhang W; Qiu Y; Xie X; Fu Y; Wang L; Cai Z
Front Oncol; 2021; 11():647526. PubMed ID: 33869045
[TBL] [Abstract][Full Text] [Related]
4. B7 Family Members in Pancreatic Ductal Adenocarcinoma: Attractive Targets for Cancer Immunotherapy.
Chen X; Li J; Chen Y; Que Z; Du J; Zhang J
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499340
[TBL] [Abstract][Full Text] [Related]
5. Enhanced B7-H4 expression in gliomas with low PD-L1 expression identifies super-cold tumors.
Chen D; Li G; Ji C; Lu Q; Qi Y; Tang C; Xiong J; Hu J; Yasar FBA; Zhang Y; Hoon DSB; Yao Y; Zhou L
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32457124
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic Suppression of B7-H4 Glycosylation Restores Antitumor Immunity in Immune-Cold Breast Cancers.
Song X; Zhou Z; Li H; Xue Y; Lu X; Bahar I; Kepp O; Hung MC; Kroemer G; Wan Y
Cancer Discov; 2020 Dec; 10(12):1872-1893. PubMed ID: 32938586
[TBL] [Abstract][Full Text] [Related]
7. Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer.
Cherif B; Triki H; Charfi S; Bouzidi L; Kridis WB; Khanfir A; Chaabane K; Sellami-Boudawara T; Rebai A
Sci Rep; 2021 Apr; 11(1):7550. PubMed ID: 33824367
[TBL] [Abstract][Full Text] [Related]
8. Role of B7 family members in glioma: Promising new targets for tumor immunotherapy.
Wang Y; Li M; Wang G; Wu H
Front Oncol; 2022; 12():1091383. PubMed ID: 36741734
[TBL] [Abstract][Full Text] [Related]
9. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
[No Abstract] [Full Text] [Related]
10. Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
Qin X; Sun W; Wang C; Li M; Zhao X; Li C; Zhang H
Reprod Biol Endocrinol; 2021 Jul; 19(1):114. PubMed ID: 34289871
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-326 attenuates immune escape and prevents metastasis in lung adenocarcinoma by targeting PD-L1 and B7-H3.
Shao L; He Q; Wang J; He F; Lin S; Wu L; Gao Y; Ma W; Dong J; Yang X; Li F
Cell Death Discov; 2021 Jun; 7(1):145. PubMed ID: 34131111
[TBL] [Abstract][Full Text] [Related]
12. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.
Emaldi M; Nunes-Xavier CE
Cells; 2022 Apr; 11(9):. PubMed ID: 35563753
[TBL] [Abstract][Full Text] [Related]
13. Blocking PD-1/PD-L1 by an ADCC enhanced anti-B7-H3/PD-1 fusion protein engages immune activation and cytotoxicity.
Xu Y; Xiao Y; Luo C; Liu Q; Wei A; Yang Y; Zhao L; Wang Y
Int Immunopharmacol; 2020 Jul; 84():106584. PubMed ID: 32422527
[TBL] [Abstract][Full Text] [Related]
14. Correlation Patterns Among B7 Family Ligands and Tryptophan Degrading Enzymes in Hepatocellular Carcinoma.
Chinnadurai R; Scandolara R; Alese OB; Arafat D; Ravindranathan D; Farris AB; El-Rayes BF; Gibson G
Front Oncol; 2020; 10():1632. PubMed ID: 33014820
[TBL] [Abstract][Full Text] [Related]
15. High expression of B7-H3 on stromal cells defines tumor and stromal compartments in epithelial ovarian cancer and is associated with limited immune activation.
MacGregor HL; Sayad A; Elia A; Wang BX; Katz SR; Shaw PA; Clarke BA; Crome SQ; Robert-Tissot C; Bernardini MQ; Nguyen LT; Ohashi PS
J Immunother Cancer; 2019 Dec; 7(1):357. PubMed ID: 31892360
[TBL] [Abstract][Full Text] [Related]
16. Beyond Programmed Death-Ligand 1: B7-H6 Emerges as a Potential Immunotherapy Target in SCLC.
Thomas PL; Groves SM; Zhang YK; Li J; Gonzalez-Ericsson P; Sivagnanam S; Betts CB; Chen HC; Liu Q; Lowe C; Chen H; Boyd KL; Kopparapu PR; Yan Y; Coussens LM; Quaranta V; Tyson DR; Iams W; Lovly CM
J Thorac Oncol; 2021 Jul; 16(7):1211-1223. PubMed ID: 33839362
[TBL] [Abstract][Full Text] [Related]
17. B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes.
Altan M; Pelekanou V; Schalper KA; Toki M; Gaule P; Syrigos K; Herbst RS; Rimm DL
Clin Cancer Res; 2017 Sep; 23(17):5202-5209. PubMed ID: 28539467
[No Abstract] [Full Text] [Related]
18. Higher preoperative serum levels of PD-L1 and B7-H4 are associated with invasive and metastatic potential and predictable for poor response to VEGF-targeted therapy and unfavorable prognosis of renal cell carcinoma.
Fukuda T; Kamai T; Masuda A; Nukui A; Abe H; Arai K; Yoshida K
Cancer Med; 2016 Aug; 5(8):1810-20. PubMed ID: 27292320
[TBL] [Abstract][Full Text] [Related]
19. Peptide Blocking CTLA-4 and B7-1 Interaction.
Podlesnykh SV; Abramova KE; Gordeeva A; Khlebnikov AI; Chapoval AI
Molecules; 2021 Jan; 26(2):. PubMed ID: 33419027
[TBL] [Abstract][Full Text] [Related]
20. Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy.
Cai D; Li J; Liu D; Hong S; Qiao Q; Sun Q; Li P; Lyu N; Sun T; Xie S; Guo L; Ni L; Jin L; Dong C
Cell Mol Immunol; 2020 Mar; 17(3):227-236. PubMed ID: 31611650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]